Clinical significance of PPARγ in patients with colorectal cancer with hyperlipidemia
-
摘要: 目的 探讨结直肠癌伴或不伴有高脂血症患者中PPARγ基因变化的临床意义,进一步明确PPARγ基因在结直肠癌发生发展及预后中的意义。 方法 回顾性调查2016年6月—2018年6月湖州市中心医院收治的315例结直肠癌患者和109例健康人群的脂质代谢水平,对2组患者的脂质代谢水平进行统计学分析。选择2017年7月—2018年5月83例结直肠癌患者,对51例结直肠癌伴有高脂血症患者和32例结直肠癌不伴有高脂血症患者采用PCR检测和酶联免疫分析(ELISA)测定患者的PPARγ基因表达量和蛋白表达水平;进一步应用PCR检测和酶联免疫分析(ELISA)测定35例结直肠癌伴有肝转移患者和48例结直肠癌不伴有肝转移患者的PPARγ基因表达量和蛋白表达水平。 结果 在回顾性调查中显示,结直肠癌患者伴有高脂血症的患者多于健康人群(P<0.05)。在PCR检测和ELISA测定中显示,与结直肠癌不伴有高脂血症组相比,结直肠癌伴有高脂血症组患者的血清和肿瘤组织中PPARγ基因表达量和蛋白表达水平更高(P<0.05);与结直肠癌不伴有肝转移患者相比,结直肠癌伴有肝转移患者的PPARγ基因表达量和蛋白表达水平更低(P<0.05)。 结论 结直肠癌伴有高脂血症患者的血清和肿瘤组织中PPARγ基因和蛋白表达水平更高,结直肠癌伴有肝转移患者的PPARγ基因和蛋白表达量更低。PPARγ基因可能参与了结直肠癌患者的脂质代谢。Abstract: Objective To investigate the clinical significance of the changes of PPARγ gene expression in colorectal cancer patients with or without hyperlipidemia, and to further clarify the significance of the PPARγ gene expression in the development and prognosis of colorectal cancer. Methods The lipid metabolism levels of 315 colorectal cancer patients and 109 healthy people from June 2016 to June 2018 were retrospectively investigated, and the lipid metabolism levels of the two groups were statistically analyzed. Eighty-three patients with colorectal cancer from July 2017 to May 2018 were recruited. PCR and ELISA were used to determine the expression of PPAR gamma gene and protein in 51 colorectal cancer patients with hyperlipidemia and 32 colorectal cancer patients without hyperlipidemia, respectively. The PPAR gamma gene expression and protein expression levels of 35 colorectal cancer patients with liver metastasis and 48 colorectal cancer patients without liver metastasis were further determined by PCR and ELISA. Results In the retrospective study,colorectal cancer patients with hyperlipidemia patients and more healthy people, and the difference had statistical significance(P<0.05). The PPAR gamma gene expression level and protein expression level in serum and tumor tissues of patients with colorectal cancer complicated by hyperlipidemia were higher than those of the group without hyperlipidemia in colorectal cancer (P<0.05). PPAR gamma gene expression and protein expression levels were lower in patients with colorectal cancer with liver metastasis than those in colorectal cancer without liver metastasis (P<0.05). Conclusion The expression of PPAR gamma gene and protein is higher in serum and tumor tissue of patients in colorectal cancer with hyperlipidemia. The expression of PPAR gamma gene and protein is lower in colorectal cancer complicated with liver metastasis. PPARγ gene plays an important role in colorectal cancer with hyperlipidemia.
-
Key words:
- Colorectal cancer /
- PPARγ /
- Hyperlipemia
点击查看大图
计量
- 文章访问数: 112
- HTML全文浏览量: 23
- PDF下载量: 0
- 被引次数: 0